Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Times Interest Earned (2022 - 2025)

Taysha Gene Therapies' Times Interest Earned history spans 4 years, with the latest figure at -$2268.3 for Q3 2025.

  • For Q3 2025, Times Interest Earned fell 110.2% year-over-year to -$2268.3; the TTM value through Sep 2025 reached -$1399.0, down 1163.99%, while the annual FY2024 figure was -$896.66, 6086.57% down from the prior year.
  • Times Interest Earned for Q3 2025 was -$2268.3 at Taysha Gene Therapies, down from -$1573.7 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$10.1 in Q3 2022 and bottomed at -$2268.3 in Q3 2025.
  • The 4-year median for Times Interest Earned is -$73.89 (2022), against an average of -$587.61.
  • The largest annual shift saw Times Interest Earned surged 83.69% in 2023 before it plummeted 9668.19% in 2024.
  • A 4-year view of Times Interest Earned shows it stood at -$41.35 in 2022, then soared by 44.9% to -$22.79 in 2023, then plummeted by 3876.23% to -$906.0 in 2024, then plummeted by 150.36% to -$2268.3 in 2025.
  • Per Business Quant, the three most recent readings for TSHA's Times Interest Earned are -$2268.3 (Q3 2025), -$1573.7 (Q2 2025), and -$1127.4 (Q1 2025).